Clinical Trial

Evaluating the Impact of Fat and Sugar Replacer Blends on Gastrointestinal Tolerance in Biscuits

Completed
View on ClinicalTrials.gov →
Summary
This study is a randomized, double-blind, crossover trial aiming at evaluating the gastrointestinal tolerance and bowel habits of sugar- and fat- replacer ingredients and blends (maltitol, polydextrose, allulose and EPG)
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-19.
Status change: Recruiting → Completed 2026-03-26
Trial Details
NCT Number NCT07372482
Lead Sponsor Mondelēz International, Inc.
Collaborators: INQUIS Clinical Research
Conditions Gastrointestinal Tolerance, Healthy Population
Enrollment 56 participants
Start Date 2025-10-28
Primary Completion 2026-02-27 (estimated)
Study Completion 2026-02-27 (estimated)
Updated on ClinicalTrials.gov 2026-03-27